4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-002466
See Remarks sold 20,000 shares at $50.39 ($1,007,800)
- See Remarks acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2025-01-02 | Option exercise 10b5-1 | +20,000 | $3.88 | $77,600 | 105,318 | D: show line 1 in the form |
| Maduck Sean See Remarks | 2025-01-02 | Sale 10b5-1 | −20,000 | $50.39 | $1,007,800 | 85,318 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $50.39 · $1,007,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2025-01-02 | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 21,986 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…